Azithromycin Mass Treatment for Trachoma Control: Risk Factors for Non-Participation of Children in Two Treatment Rounds

被引:18
|
作者
Ssemanda, Elizabeth N. [1 ]
Levens, Joshua [1 ]
Mkocha, Harran [2 ]
Munoz, Beatriz [1 ]
West, Sheila K. [1 ]
机构
[1] Johns Hopkins Univ, Wilmer Eye Inst, Dana Ctr Prevent Ophthalmol, Baltimore, MD 21218 USA
[2] Kongwa Trachoma Project, Kongwa, Tanzania
来源
PLOS NEGLECTED TROPICAL DISEASES | 2012年 / 6卷 / 03期
关键词
D O I
10.1371/journal.pntd.0001576
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Backgroud: Persistent non-participation of children in mass drug administration (MDAs) for trachoma may reduce program impact. Risk factors that identify families where participation is a problem or program characteristics that foster non-participation are poorly understood. We examined risk factors for households with at least one child who did not participate in two MDAs compared to households where all children participated in both MDAs. Methods/Principal Findings: We conducted a case control study in 28 Tanzanian communities. Cases included all 152 households with at least one child who did not participate in the 2008 and 2009 MDAs with azithromycin. Controls consisted of a random sample of 460 households where all children participated in both MDAs. A questionnaire was asked of all families. Random-intercept logistic regression models were used to estimate odds ratios (ORs) and 95% confidence intervals (CIs), control for clustering, and adjust for community size. In total, 140 case households and 452 control households were included in the analyses. Compared to controls, guardians in case households had higher odds of reporting excellent health (OR 4.12 (CI 95% 1.57-10.86)), reporting a burden due to family health (OR 3.15 (95% CI 1.35-7.35)), reduced ability to rely on others for assistance (OR 1.66 (95% CI 1.01-2.75)), being in a two (versus five) days distribution program (OR 3.31 (95% CI 1.68-6.50)) and living in a community with <2 community treatment assistants (CTAs)/1000 residents (OR 2.07 (95% CI 1.04-4.12). Furthermore, case households were more likely to have more children, younger guardians, unfamiliarity with CTAs, and CTAs with more travel time to their assigned households (p-values<0.05). Conclusions/Significance: Compared to full participation households, households with persistent non-participation had a higher burden of familial responsibility and seemed less connected in the community. Additional distribution days and lessening CTAs' travel time to their furthest assigned households may prevent non-participation.
引用
收藏
页数:11
相关论文
共 50 条
  • [1] Non-Participation during Azithromycin Mass Treatment for Trachoma in The Gambia: Heterogeneity and Risk Factors
    Edwards, Tansy
    Allen, Elizabeth
    Harding-Esch, Emma M.
    Hart, John
    Burr, Sarah E.
    Holland, Martin J.
    Sillah, Ansumana
    West, Sheila K.
    Mabey, David
    Bailey, Robin
    PLOS NEGLECTED TROPICAL DISEASES, 2014, 8 (08):
  • [2] Azithromycin Mass Treatment for Trachoma: Risk Factors for Persistent Child Non-Participation in Tanzanian Households
    Ssemanda, E. N.
    Levens, J.
    Mkocha, H.
    Munoz, B. E.
    West, S. K.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2010, 51 (13)
  • [3] Mass Treatment with Azithromycin for Trachoma Control: Participation Clusters in Households
    Ssemanda, Elizabeth N.
    Munoz, Beatriz
    Harding-Esch, Emma M.
    Edwards, Tansy
    Mkocha, Harran
    Bailey, Robin L.
    Sillah, Ansumana
    Stare, Dianne
    Mabey, David C. W.
    West, Sheila K.
    PLOS NEGLECTED TROPICAL DISEASES, 2010, 4 (10)
  • [4] Community mass treatment with azithromycin for trachoma: Factors associated with change in participation of children from the first to the second round
    Ssemanda, Elizabeth N.
    Mkocha, Harran
    Levens, Joshua
    Munoz, Beatriz
    West, Sheila K.
    CLINICAL EPIDEMIOLOGY AND GLOBAL HEALTH, 2015, 3 (01): : 37 - 43
  • [5] A Randomized Trial of Two Coverage Targets for Mass Treatment with Azithromycin for Trachoma
    West, Sheila K.
    Bailey, Robin
    Munoz, Beatriz
    Edwards, Tansy
    Mkocha, Harran
    Gaydos, Charlotte
    Lietman, Thomas
    Porco, Travis
    Mabey, David
    Quinn, Thomas C.
    PLOS NEGLECTED TROPICAL DISEASES, 2013, 7 (08):
  • [6] Active trachoma two years after three rounds of azithromycin mass treatment in Cheha district Gurage zone, Southern Ethiopia
    Fisseha Admassu
    Samson Bayu
    Abebe Bejiga
    Bemnet Amare
    BMC Pediatrics, 13
  • [7] Active trachoma two years after three rounds of azithromycin mass treatment in Cheha district Gurage zone, Southern Ethiopia
    Admassu, Fisseha
    Bayu, Samson
    Bejiga, Abebe
    Amare, Bemnet
    BMC PEDIATRICS, 2013, 13
  • [9] Risk factors for active trachoma and Chlamydia trachomatis infection in rural Ethiopia after mass treatment with azithromycin
    Edwards, Tansy
    Harding-Esch, Emma M.
    Hailu, Girum
    Andreason, Aura
    Mabey, David C.
    Todd, Jim
    Cumberland, Phillippa
    TROPICAL MEDICINE & INTERNATIONAL HEALTH, 2008, 13 (04) : 556 - 565
  • [10] Mass treatment with single-dose azithromycin for trachoma
    Solomon, AW
    Holland, MJ
    Alexander, NDE
    Massae, PA
    Aguirre, A
    Natividad-Sancho, A
    Molina, S
    Safari, S
    Shao, JF
    Courtright, P
    Peeling, RW
    West, SK
    Bailey, RL
    Foster, A
    Mabey, DCW
    NEW ENGLAND JOURNAL OF MEDICINE, 2004, 351 (19): : 1962 - 1971